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Experimental animal studies on the mechanisms of remote ischaemic conditioning (RIC)-induced cardioprotection
against ischaemia/reperfusion injury demonstrate involvement of both neuronal and humoral pathways. Auto-
nomic parasympathetic (vagal) pathways confer organ protection through both direct innervation and/or
immunomodulation, but evidence in humans is lacking. During acute inflammation, vagal release of acetylcholine
suppresses CD11b expression, a critical β2-integrin regulating neutrophil adhesion to the endothelium and
transmigration to sites of injury. Here, we tested the hypothesis that RIC recruits vagal activity in humans and has
an anti-inflammatory effect by reducing neutrophil CD11b expression. Participants (age:50  19 years; 53% fe-
male) underwent ultrasound-guided injection of local anaesthetic within the brachial plexus before applying 3  8
min cycles of brachial artery occlusion using a blood pressure cuff (RICblock). RIC was repeated 6 weeks later
without brachial plexus block. Masked analysers quantified vagal activity (heart rate, heart rate variability (HRV))
before, and 10 min after, the last cycle of RIC. RR-interval increased after RIC (reduced heart rate) by 40 ms (95%
confidence intervals (95%CI):13–66; n ¼ 17 subjects; P ¼ 0.003). RR-interval did not change after brachial plexus
blockade (mean difference: 20 ms (95%CI:-11 to 50); P ¼ 0.19). The high-frequency component of HRV was
reduced after RICblock, but remained unchanged after RIC (P < 0.001), indicating that RIC preserved vagal ac-
tivity. LPS-induced CD16þCD11bþ expression in whole blood (measured by flow cytometry) was reduced by RIC
(3615 median fluorescence units (95%CI:475-6754); P ¼ 0.026), compared with 2331 units (95%CI:-3921 to
8582); P ¼ 0.726) after RICblock.
These data suggest that in humans RIC recruits vagal cardiac and anti-inflammatory mechanisms via
ischaemia/reperfusion-induced activation of sensory nerve fibres that innervate the organ undergoing RIC.1. Introduction
The bidirectional relationship between autonomic nervous and im-
mune systems regulates cardiovascular function, metabolism, and
inflammation(Carnevale and Lembo, 2021; Perrotta et al., 2018; Ziegler
et al., 2018). In experimental animal models, the vagus nerve exerts car-
dioprotection through numerous mechanisms(Hausenloy et al., 2019;
Tsutsumi et al., 2008). Vagus nerve stimulation inhibits inflammation,
cytokine production and neutrophil CD11b surface expression through the
cholinergic anti-inflammatory pathway(Chavan et al., 2017).land).
evier Inc. This is an open accessAcetylcholine signalling through α7 nicotinic acetylcholine receptors
(α7nAChR) inhibits release of TNFα from splenic macrophages and sup-
presses F-actin polymerization, the rate-limiting step for CD11b surface
expression on circulating neutrophils(Huston et al., 2009). CD11b is a
critical β2-integrin regulating neutrophil adhesion to the endothelium and
transmigration to sites of injury(Fagerholm et al., 2006). Modulation of
leukocyte trafficking via cholinergic signaling thus suppresses the exces-
sive accumulation of neutrophils at inflammatory sites(Huston et al.,
2009).
Vagal parasympathetic activity is critical for remote ischaemicarticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ischaemia/reperfusion injury (Mastitskaya et al., 2012) and preserves
exercise capacity after myocardial infarction in rats (Machhada et al.,
2020) through time-limited, repetitive ischaemia-reperfusion applied to
a distant organ or tissue (Heusch et al., 2015; Walsh et al., 2007) Vagal
blockade prevents RIC from reducing the extent of injury after myocar-
dial infarction(Mastitskaya et al., 2012).
Activation of a vago-splenic axis is causally involved in RIC mediated
organ protection in rats and pigs (Lieder et al., 2018), suggesting that RIC
shares a common neural pathway with the cardioprotective cholinergic
anti-inflammatory (Wu et al., 2017). Whilst experimental activation of the
vagal anti-inflammatory pathway using specific vagus nerve-stimulating
devices, non-invasive approaches to activate this pathway in humans
that can be applied at scale are lacking. Laboratory data demonstrate that
RIC-induced cardioprotection requires intact afferent sensory innervation
of the remote organ undergoing RIC(Basalay et al., 2012; Jones et al.,
2009). Therefore, in this study we tested the hypothesis that nerve
blockade at the level of the brachial plexus prevents cardiac vagal and/or
anti-inflammatory effects of RIC in humans. We provide the first
proof-of-concept data in humans showing that RIC activates cardiac and
anti-inflammatory vagal activity via a neuronal pathway.
2. Methods
2.1. Study design
We conducted an experimental cross-over study in subjects scheduledFig. 1. Experimental designSequence of experimental procedures for RIC undertaken
indicated by clear bars. Three cycles of ischaemia (applied for 3 min) followed by
indicated by the collection bottles. A. For the first visit, brachial plexus block with ul
visit, a time-matched protocol was followed without brachial plexus block before th
2
for upper limb surgery at University College London Hospitals National
Health Service (NHS) Trust. The study was conducted in accordance with
the principles of the Declaration of Helsinki and approved by the London
(Stanmore) Research Ethics Committee (16/LO/0634) and registered on
Research Registry (study 6482; January 21, 2021). Subjects provided
written informed consent to participate, having given verbal consent at
least 72h before the first intervention.2.2. Inclusion/exclusion criteria
Subjects aged>18 years old scheduled for elective upper limb surgery
requiring regional anaesthesia alone were eligible. Exclusion criteria
were the presence of upper limb pathology precluding use of a blood
pressure cuff, splenectomy, a history of cardiac arrythmias and/or
abnormal preoperative electrocardiogram (conduction abnormality-
bundle branch block, bradyarrhythmia), allergy to local anaesthetic
agents, and failure to achieve loss of motor power after ultrasound guided
delivery of a local anaesthetic.2.3. Protocol
Subjects first underwent RIC after brachial plexus block was estab-
lished, prior to upper limb surgery (abbreviation RICblock used in the text;
Fig. 1A). On return to hospital for outpatient follow-up > 5 weeks after
the surgery, RIC was repeated in the absence of brachial plexus analgesia
over the same timeframe (Fig. 1B).in presence and absence of brachial plexus block. 10 min recording sessions are
5 min of reperfusion were applied. Blood samples were obtained at the times
trasound guided injection of local anaesthetic was undertaken. B. For the return
ree cycles of RIC were undertaken.
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All ultrasound-guided nerve blocks were conducted by senior anaes-
thetic staff before the surgery in a quiet dedicated procedure room
(Fig. 1A). Participants were positioned in bed at 45 degrees head-up,
with the head turned 45 to the non-operative side. Standard cardiore-
spiratory monitoring using Holter monitors were applied. Peripheral
intravenous access was established but no sedation was administered.
Under sterile conditions, a high-frequency linear array transducer (13–6
MHz, SonoSite S-Nerve; SonoSite) probe was placed over the supra-
clavicular fossa, parallel to the clavicle to obtain a short-axis view of the
divisions of the brachial plexus and the subclavian artery, lying on the
first rib. Following skin infiltration with lidocaine (1%), a 22-gauge 50
mm insulated echogenic needle (Pajunk, Geisingen, Germany) was
guided in-plane with the ultrasound beam until the needle tip was
positioned at the junction of the first rib and subclavian artery; 20 ml
0.5% bupivacaine was then administered using a single-injection tech-
nique, with intermittent aspiration under constant ultrasound visual-
isation. If paraesthesia developed, the needle tip was repositioned. After
completion of the block, patients remained fully monitored until their
transfer to the operating room. Assessments of sensory and motor blocks
were performed by one of the investigators (SK, EC, SM, GM, AR) every 5
min after local anaesthetic injection. Inability of the anaesthetised arm to
overcome gravity was required prior to the application of RIC.
2.5. Upper limb remote ischaemic conditioning
Three cycles of ischaemia/reperfusion were performed, by inflating a
12 cm wide blood pressure cuff over the upper arm for 3 min above the
systolic blood pressure to occlude the brachial artery before cuff deflation
for 5 min (Fig. 1).
2.6. ECG analysis
Three lead electrocardiogram recordings were captured using Life-
card CF digital Holter monitors (Spacelabs Healthcare), with a sampling
rate of 1024 Hz. R-R intervals from ECG data were analysed after data
cleaning. Heart rate variability (HRV) analysis was performed from the
final 5 min segments within each recording periods by investigators,
masked to the intervention (Fig. 1), in accord with Taskforce guide-
lines(Electrophysiology, 1996). Serial changes in HRV were quantified
using three established measures, including time domain, frequency
domain, and non-linear analyses (Kubios HRV Premium software,
Version 3.1.0) (Tarvainen et al., 2014), as described previously(May
et al., 2019). For time-domain measures, RR interval, minimum and
maximum heart rates were analysed. We also performed spectral analysis
using the parametric autoregressive method (AR) because it produces a
spectrum with better resolution when short data frames are used and the
spectrum can be divided into independent components(Weise et al.,
1987). High frequency (0.15–0.4 Hz) power spectral component of HRV
(AR spectrum), was used as a measure of cardiac vagal activity(Elec-
trophysiology, 1996). Low frequency (0.04–0.15Hz) power spectral
component was assessed as a measure of arterial baroreflex sensitivi-
ty(Goldstein et al., 2011). We also examined detrended fluctuation
non-linear analysis correlationmeasures, in which a series of RR intervals
are integrated and are divided into a series of regular intervals. For each
interval, the fluctuation of the data from a straight line of linear inter-
polation was calculated. We examined changes in the short-term fractal
scaling exponent (DFAα1) that quantifies the regularity of the heart rate;
DFAα1values increase with pharmacological (atropine) vagal blockade
and decrease with sympathetic blockade(Millar et al., 2010).
2.7. Flow cytometry
Blood samples were collected from patients who consented to repeat
blood draws in BD Vacutainer® sodium citrate tubes (Becton Dickinson)3
before the first 10-min period of heart rate recording and at the end of the
final 10-min period of heart rate recording. To establish that similar
levels of systemic inflammation were present in each participant before
each experiment, we quantified HLA-DR expression in monocytes, which
is amplified by exogenous or endogenously TNF produced under the
influence of IFN-γ (Arenzana-Seisdedos et al., 1988) and IL-1 (Krakauer
and Oppenheim, 1993). To determine whether vagal activation by RIC
may modulate acute inflammation, we examined whether the presence,
or absence of brachial plexus block altered myeloid (neutrophil, mono-
cyte) cell activation after the incubation with lipopolysaccharide (LPS).
Samples were incubated with low dose of LPS (10 ƞg ml1; Escherichia
coli endotoxin, serotype O111:B4, Sigma) at 37 C for 2 h with gentle
agitation. Blood samples were immediately stained as described in Sup-
plementary data (including gating strategy and antibodies used). Data
analysis was performed by investigators masked to the intervention.
Neutrophils and monocytes were identified using forward and side
scatter characteristics (Supplementary figure 1), in combination with
specific cell surface antibody staining for CD16 (clone VEP13), CD14
(clone TUK4), respectively (Miltenyi Biotec, Germany). Co-expression of
surface CD11b, CD182 [CXCR2], HLA-DR (Miltenyi Biotec, Germany)
were quantified, using frequency-minus-one and appropriate isotype
controls. Acquired data (BD LSRFortessa) were analysed using FlowJo
(BD Biosciences, Oxford, UK) software.
2.8. Statistical analysis
Manual and automated validation checks of data were undertaken.
Categorical data are summarised as percentage values. Continuous data
are presented as means (SD), or median [IQR], unless stated otherwise.
Repeated-measures analysis of variance was used to compare heart rate
and HRVmeasures before and after RIC, taking into account each subject,
timepoint and intervention (RIC with/without nerve block). Individual
comparisons between groups were calculated using post-hoc Tukey-
Kramer tests. Statistical analyses were undertaken using NCSS
2020(Kaysville, UT, USA).
2.9. Sample size calculation
Assuming a mean resting heart rate 80 10 bpm, we estimated that a
10 bpm difference (SD:10bpm) between RIC with versus without upper
limb block would require at least 15 individuals to be recruited (α¼ 0.01;
1-β¼ 0.9). Allowing for 25% drop-out rate (including failure to re-attend
for the follow-up protocol), the estimated sample size was initially
increased to 30 subjects, but revised to 20 subjects having established
>90% follow-up rate from the first 10 participants.
3. Results
3.1. Subject characteristics
A minority of the 17 participants were taking regular cardiovascular
medications (Fig. 2). None had a clinical history of ischaemic heart dis-
ease. The single subject requiring oral medication for diabetic control did
not have any clinical evidence for pre-existing neuropathy (Table 1).
Most subjects were undergoing elective upper limb surgery for long-
standing orthopaedic indications, rather than inflammatory arthropathy.
3.2. Effect of RIC on heart rate
RR-interval did not change after RIC in conditions of brachial plexus
blockade (P¼ 0.19). RIC increased RR-interval (i.e. slowed heart rate) by
40 ms (95% confidence intervals (95%CI):13–66; (Fig. 3A). In the pres-
ence of brachial plexus block, minimum RR-interval after RIC did not
change (P¼ 0.24; Fig. 3B). RIC increased minimum RR-interval by 39 ms
(95% CI:3–74); P¼ 0.03). Similarly, after RICblock, maximumRR-interval
remained unchanged (P ¼ 0.43) (Fig. 3C). Maximum RR-interval
Fig. 2. CONSORT diagram. Screening, enrolment and follow up data for study, in accord with CONSORT requirements.
Table 1
Subject characteristics Data is presented as mean with standard deviations (SD)
for parametric data and as median (25th-75th interquartile range) for non-
parametric data. Frequencies are presented with percentages (%). Age is
rounded to the nearest year. ACE-I: Angiotensin converting enzyme inhibitor.
ARB: angiotensin receptor blocker.
Age (y) 56 (36–61)
Female sex (n; %) 9 (52.9%)
Co-morbidities (n; %)
Asthma 5 (29.4%)
Atherosclerotic cardiovascular disease 0
Diabetes mellitus 1 (5.9%)
Current smoker 4 (23.5%)
Hypertension 2 (11.8%)
Active cancer 0 (0%)
Inflammatory arthritis 4 (23.5%)
At least one cardiovascular medication (n; %) 4 (23.5%)
Beta blocker 1 (5.9%)









S.M. May et al. Brain, Behavior, & Immunity - Health 16 (2021) 100299increased after RIC by 28 ms (95% CI: 2 to 58); P ¼ 0.06). Other time-
domain measures of HRV were similar between RIC and RICblock (Sup-
plementary fig. 2).3.3. Effect if RIC on frequency-domain measures of heart rate variability
Low frequency (LF) band peak frequency (autoregressive spectrum)
did not change after RIC, but in the presence of brachial plexus block, RIC
increased LF component of HRV (Fig. 4A). Baseline HF was not different
between brachial plexus block and control experiments (mean difference:
216 ms2 (95% confidence intervals: -1254 to 1685); p ¼ 0.77).
In the absence of neural block, RIC had no effect on the high-
frequency (HF) component of HRV (Fig. 4B). However, in the presence4
of brachial plexus block, HF component was reduced in response to RIC
(intervention x timepoint: F(3,3.26) P ¼ 0.03).
3.4. Non-linear analysis of heart rate variability
The detrended fluctuation analysis measure DFAα1 increased after
RIC was performed following brachial plexus blockade (0.124 (95%
confidence intervals:0.01–0.24); P ¼ 0.039), indicative of reduced vagal
tone. In the absence of brachial plexus block, DFAα1 remained un-
changed after RIC (Fig. 5).
3.5. Effect of RIC on neutrophil activation
Repeat blood samples were obtained from nine patients who con-
sented to repeat sampling. Systemic inflammation, as reflected by
monocyte HLA-DR, was similar between each experiment before RIPC
was undertaken (mean difference in HLA-DR MFI:5 (95%CI:-23 to 32); P
¼ 0.70). In blood samples collected before establishing brachial plexus
blockade (Fig. 6A), expression of CD11b on neutrophils increased after
the incubation with LPS (mean difference in median fluorescence in-
tensity (MFI): 19 (95%CI:9-28); P ¼ 0.001). In blood samples collected
after establishing brachial plexus blockade, but before RIC, expression of
CD11b on neutrophils was unaltered (P ¼ 0.72; Supplementary fig. 3).
RIC applied in conditions of brachial plexus blockade had no effect on the
magnitude of LPS-induced increases in CD11b expression (mean differ-
ence in MFI: 9 (95%CI:-1 to 19; P ¼ 0.08).
When subjects returned six weeks later to undergo RIC alone, LPS
increased surface expression (median fluorescence intensity) of CD11b
on CD16þ neutrophils by 31 units (95%CI:25-38); P < 0.001; Fig. 6A).
RIC had no effect on unstimulated CD16þCD11bþ expression (mean
difference: 3 (95%CI:-10 to 3); P ¼ 0.41). However, in blood samples
collected after RIC, the effect of LPS on surface expression of CD11b in
neutrophils was reduced, compared to the effect of LPS before the
application of RIC (mean difference:12 arbitrary units (95%CI:5-18); P ¼
0.002). There was no effect of RIC in the presence or absence of brachial
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Fig. 3. Heart rate changes before and after RIC in same individuals with/
without brachial plexus block. Pre-data point for each experiment refers to final
5 min of data recorded within 10 min period before brachial plexus block was
performed. Post refers to final 5 min of data recorded within 10 min time period
following the final 5 min washout period of the third cycle of RIC. A. Individual
datapoints for mean R-R interval in the presence, and absence, of brachial plexus
block, during pre and post-RIC recording periods (n ¼ 17 participants). B. In-
dividual datapoints for minimum heart rate achieved in the presence, and
absence, of brachial plexus block, during pre and post-RIC recording periods., p
values comparing pre versus post values (repeated-measures analysis of vari-
ance), post-hoc Tukey-Kramer test. C. Individual datapoints for maximum heart
rate achieved in the presence, and absence, of brachial plexus block, during pre
and post-RIC recording periods. p values comparing pre versus post values
















































Fig. 4. Frequency domain measures before and after RIC in same individuals
with/without brachial plexus block.A. Low frequency power. B. High frequency
power. Mean (95% confidence intervals) shown; values are shown for post-hoc

















Fig. 5. Non-linear analysis of HRV before and after RIC in same individuals
with/without brachial plexus block. Individual datapoints for DFA in the pres-
ence, and absence, of brachial plexus block, pre and post RIC. p values refer to
posthoc Tukey-Kramer testing, following repeat-measures ANOVA (n ¼ 17
participants).
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In blood samples collected before establishing brachial plexus
blockade, LPS increased surface expression of CD11b on CD14þ mono-
cytes (mean difference:9 (95%CI:1-18); P ¼ 0.04; Fig. 7A). RIC had no5
effect on CD14þCD11b expression (mean difference: 1 (95%CI:-25 to
23); P ¼ 0.98). In blood samples collected after RIC in conditions of
brachial plexus blockade, LPS had no effect on surface expression of
CD11b on monocytes (mean difference: 7 arbitrary units (95%CI:-30 to
17); P ¼ 0.73).
When the same subjects returned six weeks later, LPS increased sur-
face expression of CD11b on monocytes (by 17 arbitrary units (95%CI:7-
28); P ¼ 0.001; Fig. 7A). In blood samples collected after RIC, LPS failed
to increase surface expression of CD11b (mean difference: 5 (95%CI:-16
to 5); P ¼ 0.38). There was no effect of RIC in the presence of absence of
brachial plexus blockade on LPS-induced changes in HLA-DR expression
on CD14þ monocytes (Fig. 7B).
4. Discussion
The results of this first-in-man study demonstrate that in humans RIC
recruits cardiac vagal activity through afferent signalling from the organ/
tissue undergoing RIC. When neural transmission from the peripheral
ischaemic tissue was prevented by brachial plexus block using local
A
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Fig. 6. Flow cytometry analysis of surface markers of neutrophil activation before and after RIC in individuals with/without brachial plexus block. A. Surface
expression of CD11b on circulating CD16 neutrophils. B. Surface expression of CXCR2 (CD182) on circulating CD16 neutrophils. P values are shown for post-hoc
Tukey-Kramer testing (RIC/pre RIC versus LPS/saline control).
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Fig. 7. Flow cytometry analysis of surface markers of monocyte activation before and after RIC in individuals with/without brachial plexus block. A. Surface
expression of CD11b on circulating CD14 monocytes. B. Surface expression of HLA-DR on circulating CD14 monocytes, which were similar at baseline in each in-
dividual between experiments (block versus control). P values are shown for post-hoc Tukey-Kramer testing (RIC/pre RIC versus LPS/saline control).
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has a rapid anti-inflammatory effect, as evident from a reduced response
of neutrophils isolated from the blood collected from patients following
RIC. This anti-inflammatory effect of RIC was partially abolished in
conditions of brachial plexus block. Collectively the reported data sug-
gest that RIC activates cardiac and anti-inflammatory vagus nerve ac-
tivity in humans.
A role for afferent transmission in mediating RIC has been suggested
in experimental models in which peripheral nociception induced by skin
incisions on the abdomen established cardioprotection in mice(Jones
et al., 2009). It was also found that topical application of 0.1% capsaicin
(to stimulate C-fibre afferents) cream on the abdomen or paw before
myocardial ischaemia/reperfusion (Redington et al., 2012) (Basalay
et al., 2012) effectively reduced ischaemic damage in mice and rats via
afferent signaling involving spinal nerves, sympathetic nerves, and acti-
vation of PKCε in the heart (Jones et al., 2009). Similarly, chronic
neuropathic pain activates neurons within the anterior nucleus of para-
ventricular thalamus, which increases release of acetylcholine via the
vagus nerve activity to trigger PKCε-mediated cardioprotection following
ischaemia-reperfusion injury(Cheng et al., 2017). Pharmacological6
inhibition of extracellular signal-regulated kinase activation in the PVA
abolishes neuropathic pain-induced cardioprotection, whereas pharma-
cologic or optogenetic activation of PVA neurons confers car-
dioprotection(Cheng et al., 2017). By extension, patients with
established peripheral neuropathy (e.g. those with diabetes mellitus)
(Jensen et al., 2012; Tang et al., 2020), or who acquire loss of vagal
activity as a result of general anaesthesia, for example (May et al., 2019;
Wang et al., 2004), are unlikely to benefit from RIC.
We used three measures of heart rate variability to evaluate the
autonomic components, contributing to mediating the RIC effect. The 10
min recording period at the start and end of each protocol enabled suf-
ficient time to capture high quality ECG data for the analysis. Frequency
domain and non-linear analyses strongly suggested that parasympathetic
activation is a key feature of RIC, being independent of underlying
changes in heart rate(Monfredi et al., 2014). We performed spectral
analysis using the parametric autoregressive method (AR) because it
produces a spectrum with superior resolution using shorter data fra-
mes(Dantas et al., 2012). We used HF as an index of vagal modulation of
heart rate, which is abolished in conditions of muscarinic block-
ade(Weise et al., 1987). RIC alone preserved the high frequency power
S.M. May et al. Brain, Behavior, & Immunity - Health 16 (2021) 100299band whereas its power declined after RIC applied in the presence of
brachial plexus block, suggesting neural afferent activity is required to
maintain vagal activity in this settings. In support of this, the non-linear
measure DFA, which most closely corresponds to short-term fluctuations,
increased after RIC following brachial plexus block. Given that DFAα1
was preserved in the absence of brachial plexus block, these data suggest
that RIC initiates vagal activation since DFAα1 increases with vagal
blockade and decreases with sympathetic blockade(Millar et al., 2010).
The rapid effect of RIC in conferring cardioprotection – over minutes-
led us to focus primarily on circulating myeloid cells. As the archetypal
first responders to acute inflammation and injury, neutrophils are acti-
vated rapidly. Neutrophil depletion reduces tissue injury after myocar-
dial ischaemia-reperfusion in both patients (Palatianos et al., 2004) and
animal models of myocardial ischaemia-reperfusion injury (Litt et al.,
1989) However, dysregulated, persistent and/or over-exuberant leuko-
cyte recruitment to ischaemic tissue can fuel excessive inflammation and
exacerbate further tissue injury(Margraf et al., 2019). Our findings are
the first to provide human data in support of a direct link between
efferent vagal activity and response of neutrophils. The surface receptor
integrin CD11b/CD18 serves as a pattern recognition receptor on
phagocytes, including neutrophils, to detect pathogen and
damage-associated molecular patterns(Torres-Gomez et al., 2020). This
has direct relevance to cardioprotection, since a specific anti-CD18
monoclonal antibody reduces polymorphonuclear cell-mediated con-
tractile dysfunction in an in vitro model of myocardial
ischaemia-reperfusion injury by limiting polymorphonuclear cell accu-
mulation(Lefer et al., 1993).
Similar levels of systemic inflammation were present in each partic-
ipant before each experiment, as reflected by monocyte HLA-DR, the
expression of which is amplified by exogenous or endogenously TNF
produced under the influence of IFN-y (Arenzana-Seisdedos et al., 1988)
and IL-1 (Krakauer and Oppenheim, 1993). RIC did not prevent
LPS-induced downregulation of CXCR2 and increased expression of
monocyte HLA-DR. Our observations are consistent with laboratory
models exploring the vagal anti-inflammatory reflex, which demon-
strated a reduction, rather than complete suppression, of the inflamma-
tory response to a range of DAMPs and PAMPs(Andersson and Tracey,
2012). Nicotinic cholinergic receptors provide the receptor link between
myeloid cells and the autonomic nervous system (Kanashiro et al., 2020)
Unstimulated neutrophils isolated from human blood express α7nAChRs
and α3β4 nAChRs(Benhammou et al., 2000). Nicotine, an agonist of the
α7nAChR mediated vagal anti-inflammatory effect in macrophages, re-
duces levels of CD11b on the surface of neutrophils in a dose-dependent
manner, by suppressing F-actin polymerization, the rate-limiting step for
CD11b surface expression(Huston et al., 2009). Vagus nerve stimulation
attenuates neutrophil surface CD11b expression only in the presence of
an intact and innervated spleen(Huston et al., 2009). Reduced expression
of CD11b, which also serves as a receptor for complement C3b, limits
cell-mediated cytotoxicity, chemotaxis and phagocytosis.
A rapid decline in the surface expression of HLA-DR is observed in
monocytes obtained from patients after acute myocardial infarction(-
Haeusler et al., 2012). Circulating CD14þHLA-DRneg/low monocytes
secrete high levels of TNFα, IL-6, and IL-1β which promote proin-
flammatory immune responses; in the expansion of this monocyte pop-
ulation after myocardial infarction correlates with both cardiac damage
and physiological function(Fraccarollo et al., 2020). However, RIC had
no effect on CD14þHLA-DR surface expression. Similarly, expression of
the chemokine receptor CXCR2, deficiency of which limits neutrophil
recruitment and the extent of myocardial infarction size, was not altered
by RIC in the presence or absence of brachial plexus block.
Several randomised clinical trials, particularly in elective cardiac
surgery, have failed to show consistent benefits of RIC on clinical out-
comes(Heusch and Rassaf, 2016). Our study provides direct human
translational data in support of the laboratory findings by demonstrating
that autonomic modulation contributes to the beneficial effects of RIC.
Bidirectional feedback mechanisms between the heart and the brain7
require both neural and humoral pathways for effective RIC(Basalay
et al., 2018). The frequency and ease with which the autonomic
component of RIC may be disrupted is likely to account for the results in
several neutral trials. For example, peripheral neuropathy in patients
with diabetes mellitus and metabolic syndrome is very common (Kaza-
mel et al., 2021). Markedly reduced vagal activity is common in in-
dividuals who are physically deconditioned(Ackland et al., 2018, 2019;
Machhada et al., 2017). Furthermore, neural processing in autonomic
pathways within the central nervous system is profoundly disrupted by
anaesthetic agents(Jin et al., 2012; Wang, 2009).
The development of this human model enabled each subject to serve
as their own control while remaining masked to laboratory outcomes.
Capturing both autonomic and immunologic readouts added further
complementary data to address the central hypothesis that RIC stimulates
cardiac and anti-inflammatory vagal pathways. We were unable to ran-
domise the sequence of block versus control RIC, as subjects gave consent
prior to elective upper limb surgery. Similarity in both autonomic and
inflammatory measures at the start of both control and block protocols
suggest that the impact of randomising the sequence of interventions
would not be significant. Brachial plexus nerve block is not a minor
procedure for subjects who do not require surgery, hence the choice of
participants were preoperative patients. It is important to highlight that
ultrasound-guided brachial plexus block was undertaken without seda-
tion, which alters autonomic function(Karmali et al., 2017). Although
data were captured only during the protocol period, we have established
that this model of brachial plexus block serves as a potentially useful tool
over the longer term to further dissect the mechanisms of RIC in humans.
In summary, we have shown, for the first time in humans, that RIC
recruits vagal cardiac and anti-inflammatory mechanisms, most likely via
ischaemia/reperfusion-induced activation of sensory nerve fibres that
innervate the organ or tissue undergoing RIC – the phenomenon previ-
ously identified in laboratory animal models. Closing this translational
gap in mechanistic knowledge in humans explains, in part, the variable
effect of RIC in conferring cardiac and renal protection(Basalay et al.,
2018). Our data suggest that a personalised medicine approach may
benefit individuals who are capable of mounting an integrated innate
response to RIC, that involves recruitment of vagal mechanisms.
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